当前位置: 首页 > 期刊 > 《医学信息》 > 202010
编号:13497959
IL-10基因-819T/C多态性与糖尿病肾病易感性的Meta分析(4)
http://www.100md.com 2020年3月12日 《医学信息》 202010
     [9]Mtiraoui N,Ezzidi I,Kacem M,et al.Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients[J].Diabetes Metab Res Rev,2009,25(1):57-63.

    [10]Fathy SA,Mohamed MR,Ali MAM,et al.Influence of IL-6,IL-10,IFN-γ and TNF-α genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients[J].Biomarkers,2019,24(1):43-55.

    [11]Kung WJ,Lin CC,Liu SH,et al.Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy[J].Diabetes Technol Ther,2010,12(10):809-813.

    [12]Ma DH,Xu QY,Liu Y,et al.Association between interleukin-10 gene polymorphisms and susceptibility to diabetic nephropathy in a Chinese population[J].Genet Mol Res,2016,15(2):10.

    [13]Yin Q,Zhai Q,Wang D,et al.Investigation on the association between inerleukin-10 -592C/A,819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy[J]. Int J Clin Exp Pathol,2015,8(11):15216-15221.

    [14]馬东红,刘云,石岩,等.IL-10基因多态性与中国北方人群糖尿病肾病易感性的关系[J].重庆医学,2018,47(26):3390-3393.

    [15]葛景利,代青湘.糖尿病肾病治疗的研究进展综述[J].外科,2019,8(3):78-83.

    [16]卢葵花,黎荣.血清HPA及IL-10与2型糖尿病合并肾病的相关性分析[J].国际检验医学杂志,2018,39(14):1687-1690.

    [17]Sinuani I,Beberashvili I,Averbukh Z,et al.Role of IL-10 in the progression of kidney disease[J].World J Transplant,2013,3(4):91-98.

    编辑/肖婷婷, 百拇医药(胡玲 王思思 周乐汀)
上一页1 2 3 4